Treatment Evolution after COPD Diagnosis in the UK Primary Care Setting

Open Access

Peer-reviewed

Research Article

Keele E. Wurst ,

* E-mail: keele.e.wurst@gsk.com

Affiliation Worldwide Epidemiology, GlaxoSmithKline R&D, Research Triangle Park, North Carolina, United States of America
⨯
Yogesh Suresh Punekar,

Affiliation Global Health Outcomes, GlaxoSmithKline R&D, Uxbridge, Middlesex, United Kingdom
⨯
Amit Shukla

Affiliation Worldwide Epidemiology, GlaxoSmithKline R&D, Upper Providence, Pennsylvania, United States of America
⨯

Reader Comments (1)

Chronic obstructive pulmonary disease
Is the Subject Area "Chronic obstructive pulmonary disease" applicable to this article?

Thanks for your feedback.
Corticosteroid therapy
Is the Subject Area "Corticosteroid therapy" applicable to this article?

Thanks for your feedback.
Bronchodilators
Is the Subject Area "Bronchodilators" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Asthma
Is the Subject Area "Asthma" applicable to this article?

Thanks for your feedback.
Primary care
Is the Subject Area "Primary care" applicable to this article?

Thanks for your feedback.
Pulmonology
Is the Subject Area "Pulmonology" applicable to this article?

Thanks for your feedback.
Medicine and health sciences
Is the Subject Area "Medicine and health sciences" applicable to this article?

Thanks for your feedback.